Home Biz Break: Pharmacyclics to sell in biggest biotech deal of the year, reports say
 

Keywords :   


Biz Break: Pharmacyclics to sell in biggest biotech deal of the year, reports say

2015-03-05 00:53:04| Biotech - Topix.net

Today: Johnson & Johnson plans to buy Sunnyvale drugmaker Pharmacyclics for more than the $17 billion, according to the Financial Times. In a year that has already seen several blockbuster biotechnology deals, Sunnyvale drugmaker Pharmacyclics is set to be the biggest purchase so far, according to recent reports.

Tags: year say sell reports

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
05.10Eastern North Pacific Tropical Weather Outlook
05.10Atlantic Tropical Weather Outlook
05.10Weekly Recap: BASF, Beckers, Allnex, Sherwin-Williams Top This Weeks Stories
05.10Hurricane Kirk Graphics
05.10Hurricane Kirk Forecast Discussion Number 24
05.10Hurricane Kirk Wind Speed Probabilities Number 24
05.10Hurricane Kirk Forecast Advisory Number 24
05.10Hurricane Kirk Public Advisory Number 24
More »